Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Join | Sign in
Home>Resources>Application Notes

  Application Notes

Africa and Design of Experiments

Syrris Ltd
Analysing Endotherms using Atlas

Syrris Ltd
Analysis of ‚ ß-Lactam Antibiotics, for their identification in food p

DeltaDOT
Analysis of E.coli lysate using Peregrine High Performance Capillary E

deltaDOT
Biphasic Reactions

Syrris Ltd
Cleaning Flow Reactors

Syrris Ltd
Cleaning Microreactors

Syrris Ltd
Creating dose-response curves for cell-based and biochemical assays wi

Tecan Group Ltd.
Cytotoxicity in Cells: Easy Determination Using Lonza ViaLight Plus an

Molecular Devices
<< 1 2 3 4 5 >>
showing results 1 to 9 of 38
Scientific News
Drugs that Activate Brain Stem Cells May Reverse Multiple Sclerosis
NIH-funded study identifies over-the-counter compounds that may replace damaged cells.
Allergy Drug Inhibits Hepatitis C in Mice
NIH study suggests alternative drug to treat virus.
Saccharin Shows Promise as Cancer Inhibitor
Researchers have found that the artificial sweetener can inhibit cancer cell growth.
Treating Canine Periodontal Disease
The class of compounds, designed to resolve inflammation, has potential to treat chronic disease in animals and humans.
‘Warhead’ Molecule Targets Deadly Bacteria
Boston college chemists target bacterial lipids to label deadly bacteria, spare healthy cells.
Garlic Could Aid Cystic Fibrosis Fight
A chemical in garlic kills bacteria that cause deadly infections in people with cystic fibrosis, University of Edinburgh research shows.
UGA Researchers Discover Potential Treatment for Drug-resistant Tuberculosis
Researchers have developed a new small molecule drug as a treatment against multi-drug resistant tuberculosis.
A Protein's Novel Role In Several Types Of Cancers Discovered
Stanford ChEM-H scientists are helping to develop a novel cancer therapy based on a new finding of a protein that inadvertently promotes cancer growth.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Grant will Help Develop More Powerful Disinfectants
$200,000 grant awarded to develop the next generation of antibacterial cleansers and disinfectants.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters